Introduction
Ventilator associated pneumonia refers to bacterial pneumonia developed in patients who have been mechanically ventilated for a duration of more than 48 hrs. 1 It is the second most common nosocomial infection in the intensive care unit (ICU) and the most common in mechanically ventilated patients. The incidence of VAP ranges from 13 to 51 per 1000 ventilator days. 2 The incidence of VAP varies among different studies, depending on the definition, the type of hospital or ICU, the population studied, and the level of antibiotic exposure. 3 The causative Ventilator associated pneumonia is the second most common nosocomial infection in the intensive care unit (ICU) and the most common in mechanically ventilated patients. The present study was undertaken to elucidate the bacteriological profile causing VAP in our institution and finding its incidence by recent NHSN guidelines. Study was conducted for 1 year study period (June 2017-May 2018). All the patients were monitored from the time of inclusion in the study for the entire duration of the hospital stay. Relevant details of the patients were included in the study in a structured proforma and surveyed for possible VAP as per the recent NHSN guidelines. Gram stain and semi-quantitative cultures of Purulent Endotracheal aspirates of patients were processed as per standard protocols. The clinical isolates obtained were identified by both conventional and automated methods. Among 104 patients 31 developed PVAP (possible VAP) during their ICU stay; of these two patients had 2 episodes of VAP each, incidence of VAP was 32%. The overall incidence rate was 38.42 /1000VD. Most common isolate was Acinetobacter baumani (38%) followed by Pseudomonas aeruginosa (22%), Klebsiella pneumoniae (16%) and Escherichia coli (13.51%). The overall mortality was 48.38%. There is a need for compilation of local epidemiological data at all centers, as such information can help in guiding the initial empirical therapy which would reduce the ICU stay thereby the rate of VAP. The study was conducted to find the incidence of PVAP by using the recent definition guidelines and to elucidate bacteriological profile of VAP among mechanically ventilated patients admitted in RICU department of Gandhi
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Hospital. Acinetobacter spp., Pseudomonas spp, Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus were identified as the common VAP pathogens Although mechanical ventilation (MV) is a life-saving intervention, it has its own potential complications. VAP occurrence is increased with prolonged length of ICU stay. 04,05 A method to reduce the risk of VAP is to extubate patients as soon as possible as various randomized, and observational studies have shown that the risk of developing VAP increases with the duration of an endotracheal tube remaining in place. 06 The use of appropriate weaning protocols and the regular assessment of sedation requirements are effective in reducing the duration of MV and hence the incidence of VAP. 07
Materials and Methods

Setting and subjects
The prospective study was conducted over a period of 1 year from June-2017 to May 2018 of all mechanically ventilated patients admitted in RICU of Gandhi medical college and hospital a tertiary care hospital in Telangana, India.
An ethical clearance to conduct this study was obtained from institutional ethical committee prior to commencement of the study.
The subjects consisted of all adult patients (>18yrs) presented with acute respiratory failure due to a variety of causes and required mechanical ventilation for >48 hours.
Patients not admitted in RICU (Respiratory Intensive care units) i.e. admitted in general wards, other ICU's or treated in other departments, Patients with pneumonia prior to MV or within 48 hours of MV and Patients on high frequency ventilation or extracorporeal life support or brain dead, Lung expansion devices such as intermittent positive-pressure breathing (IPPB), Nasal positive endexpiratory pressure (nasal PEEP), Continuous nasal positive airway pressure (CPAP, hypo CPAP) 08 were excluded.
Study design and data collection
All the relevant details of the patients included in the study, i.e. name, age, sex, occupation, diagnosis, duration of illness, reason for mechanical intubation, whether any surgical intervention done, history of antibiotic usage, site of infection, past history, family history, were taken in a structured proforma.
Procedure for data collection
All patients included in the study were monitored daily for the development of VAP using recent CDC NHSN clinical and microbiological criteria until either discharge or death.
The clinical parameters were recorded from their medical records and bedside charts. Details of antibiotic therapy, surgery, use of steroids, duration of hospitalization, presence of neurological disorders, and impairment of consciousness were also noted
Criteria for diagnosis of VAP
Oxygen demand on ventilator was measured by fraction of inspired oxygen (FiO2) or positive end-expiratory pressure (PEEP).
Criteria for defining VAC
Ventilator associated condition is defined as worsening of oxygenation sustained for at least 2 CL immediately after the baseline period of stability or improvement of 2 days. 
Criteria for defining IVAC
Microbiological techniques
Specimen collection
Endotracheal aspirate (ETA) was chosen as sample because it is non-invasive and was proved to give similar results when compared with invasive procedures like PSB (Protected specimen brush), BAL (Broncho alveolar lavage).The ETA was collected under aseptic precaution in the patient qualifying IVAC criteria using a 22-inch Ramson's 12 F suction catheter with a mucus extractor (Lukens trap shown in the figure 1) , which was gently introduced through the endotracheal tube for a distance of approximately 25-26 cm.
Specimen processing
Specimen was immediately processed after collection. Gram stain of the sample was done 09 .
To consider it as a purulent sample, Gram stain should show : >25 PMN neutrophils/LPF and <10 squamous epithelial cells. One of those purulent gram stain is shown in figure 2 . Semi-Quantitative cultures were done by serial dilution in sterile normal saline as 1/10, 1/100, 1/1000, and 0.01 ml of 1/1,000 dilution was inoculated on 5% sheep blood agar, Chocolate agar, MacConkey agar and Sabourad's Dextrose agar. Inoculated plates were incubated at 37 0 C for 18-24 hrs .All
Worsening of oxygenation defined as  FiO2: ↑ in daily minimum FiO2 of ≥0.20 (20%) after 2 calendar days ofstability (OR)  PEEP: ↑ in the daily minimum PEEP of ≥3 cm H2O after 2 calendar days of stability (PEEP values of 0 cm-5 cm H2O are considered equivalent) plates were checked for growth overnight and then after 24-48 hr of incubation. SDA slants were checked up for 4 weeks. Colony count was done and expressed as number of colony forming units per ml (CFU/ml), The microorganisms isolated at a concentration of more than 10 5 CFU/ ml were considered as significant and also if the colony count is less then purulent gram stain was taken into consideration and colonies were identified based on standard bacteriological procedures including colony morphology and biochemical reactions 10 . Subsequently Further confirmation of identification was done by automated Vitek2 system.
Results and Discussion
Over the 1 year study period (June 2017 to May 2018) 204 patients were admitted in the respiratory intensive care unit were prospectively evaluated. Of these 28 patients (13.72%) were not intubated, as there were no indications for mechanical ventilation.
Among those requiring MV, 72 (35.29%) patients were mechanically ventilated for less than 48 hours therefore excluded from the study.
Incidence 104 (50.98%) patients received mechanical ventilation for more than 48 hours and were monitored daily. Of these 104 patients, 31 (15.19%) patients developed VAP during their ICU stay. 2 patients had 2 episodes of VAP each. Incidence of VAP was 31.73% as shown in Table 1 .
Formula to calculate VAP rate:
VAP Episodes Rate = ----------------------x 1000
Total VD
The overall incidence rate was 38.42 per 1000 ventilator days.
VAE was more in the patients staying for more than 10 days and it was less when the duration of mechanical ventilation was less. Number of patients was more in <5days MV but the development of VAP was less though VAC was there. Patients on MV for >15days were less but most of them developed VAP signifying the role of duration of MVfor VAP.
The incidence of VAP was more common in males (71%) than females (29%) as shown in figure 3 . Male sex was found to be one of the non-modifiable patient related risk factor for the development of VAP.
Organism wise distribution of VAP
Acinetobacter spp was the most common organism (37.83%) among which Acinetobacte rbaumanii was more common than A. lowfii. Pseudomonas spp (21.62%) were the second most common organism followed by Klebsiella spp (16.21%), Escherichia coli (13.51%) while Elizabethkingia meningoseptica and Enterobacter cloacae were the least common one among gram negative organisms being only one isolate (2.70%) each. The 2 isolates of Staphylococcus aureus accounting for (5.40%) were the only gram positive organism identified. No fungal isolate found in any of the sample tested ( Fig. 4 and Table 2 ).
Outcome
In this study the crude mortality rate of patients with VAP was 48.38%.
Novelty of our work comes from being the first to study VAP according to newer NHSN guidelines in Telangana by taking into consideration clinical, radiological and microbiological results together. VAP accounts for one-fourth of the infections occurring in critically ill patients and is the reason for half of antibiotic prescriptions in mechanically ventilated patients. Several countries have reported mortality rates ranging from 24% to 76% (Table 3) . This study highlights the need for urgent infection control, planning, as well as multidisciplinary team participation to combat VAP. This includes implementing measures such as education, increased awareness of hand hygiene measures, reduction of the duration of mechanical ventilation and use of other VAP bundles, all of which have been proven to reduce the risk of VAP infections.
Regarding limitations of this study, Findings emerging out of this study may not be generalized as a single centre study limits the generalizability of the findings to other regions of the country. More studies with bigger sample size are warranted.
In conclusion, the findings showed VAP as a problem in the ICU setting, with high percentage of gram negative pathogens and high mortality. Further, to have a comprehensive pan-India picture, multicentric studies with high number of patient population need to be initiated. Majority of these are caused by highly resistant strains and also the frequency of specific pathogens causing VAP may vary by hospital, patient population, and exposure to antibiotics, type of ICU patients and changes over time, emphasizing the need for timely local surveillance data. Adherence to the best practices standards of hospital infection control requires an interdisciplinary team of clinical microbiologists, physicians and hospital infection control nurses, to collectively manage these patients.
